Aro Biotherapeutics, a University City-based gene-therapy maker founded by two former Johnson & Johnson scientists, has raised $88 million from J&J and other investors in the U.S. and Europe to help bring its line of RNA-based drugs to market.

Read the full article at: www.inquirer.com

The following two tabs change content below.
Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.